CTL ImmunoTherapies Pages on BioPortfolio:

BioPortfolio - CTL ImmunoTherapies - Profile
View the current CTL ImmunoTherapies Page on BioPortfolio.com ... CTL ImmunoTherapies, located in Chatsworth, California, is a biotechnology company
...
http://www.bioportfolio.com/biocorporate/3114-CTL+ImmunoTher...

BioPortfolio - Biocorporate Search biotechnology
CTL ImmunoTherapies, located in Chatsworth, California, is a biotechnology company focusing on the discovery, development and manufacturing of theraputic
...
http://www.bioportfolio.com/biocorporate/search.php?page=14&...

Cancer Cell Therapy Markets
(Micromet, Inc.) 194; 4.6.7 Corixa (Acquired by GlaxoSmithKline) 194; 4.6.8 CTL Immunotherapies 194; 4.6.9 Dendreon 194; 4.6.10 GenEra 194 ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_1026.html...

BioPortfolio - Immunotherapy - InDepth
Immunotherapies have become an integral part of modern treatment ... Characterization of Gag and Nef-specific ELISpot-based CTL responses in HIV-1
infected ...
http://www.bioportfolio.com/indepth/Immunotherapy.pdf...

BioPortfolio - Ctl Immunotherapies Chatsworth
Ctl Immunotherapies Chatsworth - BioPortfolio. ... Ctl Immunotherapies Chatsworth Pages on BioPortfolio: . ...
http://www.bioportfolio.com/search/_Ctl_Immunotherapies___Ch...

BioPortfolio - Argos Therapeutics - Profile
cell product capable of inducing a potent proinflammatory CTL response. Dendritic cells (DC) for the immunotherapy of cancer and infectious...10th
September ...
http://www.bioportfolio.com/biocorporate/18700-Argos%2BThera...

BioPortfolio - Austin Research Institute - Profile
Advances of MUC1 as a target for breast cancer immunotherapy. ... Cytoplasmic delivery of proteins or CTL epitopes is crucial for the...15th September, 2006
...
http://www.bioportfolio.com/biocorporate/1098-Austin+Researc...

BioPortfolio - Austin Research Institute - Profile
Cancer Immunotherapy Laboratory, Burnet Institute incorporating Austin- Histol ... Cytoplasmic delivery of proteins or CTL epitopes is crucial for ...
http://www.bioportfolio.com/biocorporate/1098-Austin%2BResea...

BioPortfolio - sublingual technology
Biotechnology News Ligand -B moreno. nkt. ctl. gc. antitumor . ... Efficacy, dosage concerns unresolved on sublingual immunotherapy . ...
http://www.bioportfolio.com/search/sublingual_technology.htm...

Results from other life science and pharmaceutical sites:

Improving alloreactive CTL immunotherapy for malig...[Cancer ...
PubMed is a service of the US National Library of Medicine that includes over 18 million citations from MEDLINE and other life science journals for ...
http://www.ncbi.nlm.nih.gov/pubmed/17823798...

Immunotherapy with autologous HIV-specific CTL.
CONCLUSIONS: Immunotherapy with ex vivo-expanded autologous HIV-specific CTL is safe and feasible. Because of preliminary encouraging results, ...
http://gateway.nlm.nih.gov/MeetingAbstracts/102208596.html...

The multi-epitope approach for immunotherapy for cancer ...
One approach to development of specific cancer immunotherapy relies on the induction of cytotoxic T lymphocytes (CTL) specific for tumor-associated
antigens ...
http://www.ncbi.nlm.nih.gov/pubmed/9544234...

Adoptive immunotherapy of viral infections with genetically ...
Adoptive immunotherapy of viral infections with genetically modified cytotoxic T cell (CTL) clones. Riddell SR, Walter BA, Gilbert M, Corey L, Greenberg PD; ...
http://gateway.nlm.nih.gov/MeetingAbstracts/102213953.html...

Exploiting T cell receptor genes for cancer immunotherapy
Keywords: cancer, CTL, immunotherapy, gene therapy, TCR. Top. Abstract. > Therapeutic vaccination. Conventional adoptive immunotherapy ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=18...

CTL Adoptive Immunotherapy Concurrently Mediates Tumor Regression ...
Tumor escape and recurrence are major impediments for successful immunotherapy. It is well-documente...
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&d...

RCC therapeutic vaccine strategies, or immunoatherapy
Briefly will be described immunotherapies for cancer in general. ... cell vaccines have not been very successful in activating a specific CTL response.
...
http://www.brown.edu/Courses/Bio_160/Projects2000/RCC/RCCthe...

CTL adoptive immunotherapy concurrently mediates tumor regression ...
Moreover, TEV were significantly less responsive to eradication by CTL adoptive immunotherapy paradigms as a consequence of increased Fas resistance. ...
http://www.ncbi.nlm.nih.gov/pubmed/16517705...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.